AbbVie Inc. (ABBV)
US listed · Healthcare · Drug Manufacturers - General
This page tracks AbbVie Inc. (ABBV) with live price data, technical indicators (RSI, MACD, moving averages, Sharpe ratio), and AI-powered analysis. Our scanner continuously reviews ABBV against ~5,000 North American equities — fusing market fundamentals with frontier AI to surface high-conviction opportunities before they break out.
New to these indicators? RSI, MACD, and moving averages explained — plus how AI forecasting works.
Latest AI Analysis
Updated Jun 28, 2026ABBV shows a solid near-term technical setup: RSI at 76.53 is elevated but reflects genuine momentum in a stock that has rallied from ~$210 to the current 52-week high of $253.35, with a strongly positive MACD (histogram +2.4) confirming upside participation. Catalysts are real — Health Canada approval for Boey and the announced Apogee Therapeutics acquisition provide fundamental support, and the stock trades as a high-quality, low-beta (0.24) defensive name with a 2.85% dividend in an Extreme Fear tape. The composite pre-screen score of 2.01 is marginal-to-moderate, and the elevated RSI is a modest caution flag, but no specific contradicting catalyst exists to override the directional lean.
No buy/sell call, target or confidence is shown: tracked against what stocks did next, they have not predicted direction.
ABBV — Frequently Asked Questions
Is AbbVie Inc. (ABBV) a buy right now?
StockTracker AI does not rate ABBV a buy or a sell. As of June 28, 2026 its AI analysis sets out the evidence and the risks instead. Tracked against what stocks did next, its buy/sell calls have not predicted direction, so they are not shown. This is informational analysis, not financial advice or a recommendation to trade — confirm it against your own research and risk tolerance.
What is the AI price forecast for ABBV?
StockTracker AI generates a probability-weighted 30-day price forecast for ABBV — a mathematical baseline (regression on recent prices) adjusted by an AI model for news, earnings proximity, and the current macro regime, with bull/base/bear scenarios. Sign in to generate the latest forecast.
How does StockTracker AI analyze ABBV?
Each scan screens ABBV on momentum, RSI, MACD, moving-average posture, Sharpe ratio, and 1-year CAGR to build a composite score, then a frontier AI model reviews the full picture — fundamentals, macro context, and recent news — to confirm or challenge the signal before it's surfaced.
Get the full picture for ABBV — free.
Add ABBV to a watchlist for instant scanner alerts. Run an on-demand 30-day AI price forecast. See the full historical signal track record. Free tier, no credit card.
Related stocks in Healthcare
Get scanner alerts and AI forecasts for ABBV
Free tier includes daily AI analysis, charts with indicators, and a 3-stock watchlist. No credit card.
Get Started →